- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05173922
"Safety in Dementia": An Online Caregiver Intervention
Study Overview
Status
Intervention / Treatment
Detailed Description
Aim 1: To test the efficacy of Safety in Dementia (SiD) on firearm safety decision quality and behaviors, among a national sample of informal caregivers of community-dwelling people with dementia and firearm access (n=500).
Aim 2: To compare varied methods in reaching informal caregivers. Aim 3: To explore stakeholder longitudinal experiences with SiD and firearm-related decisions.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Anschutz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Live in United States
- Speak English or Spanish
- Informal caregiver for community swelling person with dementia and firearm access
- Access to the internet
Exclusion Criteria:
- In legal custody or institutionalized
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Safety in Dementia
Safety in Dementia is an online tool that, in a stepwise fashion, guides a caregiver individual through decisions related to firearm access for a person with dementia.
It includes information and a comparison of the options and their risks and benefits.
It guides the caregiver through clarification of personal feelings and values and identifying their decision/plan.
|
Safety in Dementia is an online tool that, in a stepwise fashion, guides a caregiver individual through decisions related to firearm access for a person with dementia.
It includes information and a comparison of the options and their risks and benefits.
It guides the caregiver through clarification of personal feelings and values and identifying their decision/plan.
The control group will view national Institute on Aging Home Safety Checklist.
|
|
Active Comparator: Web control
The control group will view National Institute on Aging Home Safety Checklist.
|
Safety in Dementia is an online tool that, in a stepwise fashion, guides a caregiver individual through decisions related to firearm access for a person with dementia.
It includes information and a comparison of the options and their risks and benefits.
It guides the caregiver through clarification of personal feelings and values and identifying their decision/plan.
The control group will view national Institute on Aging Home Safety Checklist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Preparation for Decision Making
Time Frame: During baseline assessment (specifically, after receiving randomization allocation), 2 weeks, 2 months, 6 months
|
The Preparation for Decision Making Scale assesses perception of how useful a decision aid is in preparing for subsequent decision-making. Scores range from 1-5, calculated from the sum of 10 constructs (each ranging from 1, 'not at all' to 5, 'a great deal'). The total score is calculated by first summing the 10 items and dividing by 10 to find an average item response score. Then, we subtract 1 from the summed score and multiply this by 25 to convert the final score to a 0-100 scale with higher scores indicating higher perceived levels of preparation for decision making (higher = better). The scale has high test reliability (0.944) and discriminates significantly between different decision support interventions. |
During baseline assessment (specifically, after receiving randomization allocation), 2 weeks, 2 months, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Decision Self-Efficacy
Time Frame: baseline/pre-intervention, 2 weeks, 2 months, 6 months
|
The Decision Self-Efficacy Scale measures confidence in ability to make decisions; transformed scores range from 0 (extremely low, worst outcome) to 100 (extremely high self-efficacy, best outcome).
|
baseline/pre-intervention, 2 weeks, 2 months, 6 months
|
|
Number of People With Dementia Who Retained Firearm Access
Time Frame: 2 weeks, 2 months, 6 months
|
Firearm access for the person with ADRD will be assessed with scales we have used in prior work, allowing nuanced (but efficient) description of firearm access (on a scale ranging from access to multiple loaded firearms to no access to any firearms).
For reporting and analysis, we will use binary categorization (caregiver reports that person with dementia still has access to 1+ firearm [1] versus person with dementia no longer has access to any firearms [0])
|
2 weeks, 2 months, 6 months
|
|
Number of Participants Who Took Action to Reduce Firearm Access for Person With Dementia
Time Frame: Baseline, 2 weeks, 2 months, 6 months
|
At each time point, participants self-reported if they have taken any steps to reduce firearm access for the person with dementia.
Nine response options associated with this question are used to calculate this binary outcome (1+ actions taken versus no action taken).
If they selected 'yes' to any of the following options, their outcome was '1+ action taken' (1); if they selected 'no' to all, their outcome was 'no action taken' (0).
The nine response options were: (1) used a/more locking devices, (2) used a/more locking safes or gun lockboxes, (3) gave a/more guns to a trusted family member for temporary safekeeping, (4) gave a/more guns to a trusted friend for temporary safekeeping, (5) stored a/more guns at a store or range that has firearm storage, (6) stored a/more guns at a law enforcement agency temporarily, (7) gave a/multiple guns to law enforcement permanently, (8) sold, gave or transferred a/multiple guns to family or friends, and (9) sold a/multiple guns to the public.
|
Baseline, 2 weeks, 2 months, 6 months
|
|
Firearm Injury
Time Frame: baseline/pre-intervention, 2 weeks, 2 months, 6 months
|
We will assess injuries involving the person with ADRD and a firearm.
Participants will be asked about any such incidents in the prior year (baseline) or since enrollment (follow-up) and a brief description.
|
baseline/pre-intervention, 2 weeks, 2 months, 6 months
|
|
Caregiver Burden
Time Frame: 2 weeks
|
The short-form Zarit Burden Interview has scores ranging from 0-48, calculated from 12 items (measured on a 5-point scale from 0, never to 4, nearly always); scores range from 0 to 12 with higher scores reflecting higher burden.
|
2 weeks
|
|
Positive Aspects of Caregiving
Time Frame: 2 weeks
|
The Positive Aspects of Caregiving Scale has scores ranging from 0-36, calculated from the sum of 9 items (measured on a 5-point scale ranging from 0, disagree a lot, to 4, agree a lot, on statements such as feel more useful), with higher scores indicating more positive caregiving experiences.
|
2 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Betz ME, Portz J, Knoepke C, Ranney ML, Fischer SM, Peterson RA, Johnson RL, Omeragic F, Castaneda M, Greenway E, Matlock D. The Effect of the "Safety in Dementia" Online Tool to Assist Decision Making for Caregivers of Persons With Dementia and Access to Firearms : A Randomized Trial. Ann Intern Med. 2024 Dec;177(12):1630-1640. doi: 10.7326/ANNALS-24-00763. Epub 2024 Oct 22.
- McCarthy V, Portz J, Fischer SM, Greenway E, Johnson RL, Knoepke CE, Matlock DD, Omeragic F, Peterson RA, Ranney ML, Betz ME. A Web-Based Decision Aid for Caregivers of Persons With Dementia With Firearm Access (Safe at Home Study): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2023 Jan 31;12:e43702. doi: 10.2196/43702.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Mental Disorders
- Behavioral Symptoms
- Neurocognitive Disorders
- Dementia
- Tauopathies
- Neurodegenerative Diseases
- Self-Injurious Behavior
- Behavior
- Alzheimer Disease
- Suicide
- Public Health
- Environment and Public Health
- Accident Prevention
- Accidents
- Safety
Other Study ID Numbers
- 21-4084
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer Disease
-
ProgenaBiomeWithdrawnAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3 | Alzheimer Disease 4 | Alzheimer Disease 7 | Alzheimer Disease 17 | Alzheimer Disease 5 | Alzheimer Disease 6 | Alzheimer Disease 8 | Alzheimer Disease 10 | Alzheimer... and other conditionsUnited States
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
Stanford UniversityNot yet recruitingMCI With Increased Risk for Alzheimer Disease | Alzheimer s DiseaseUnited States
-
University of California, Los AngelesRecruitingAlzheimer Disease | Dementia Alzheimer Type | Alzheimer&Amp;#39;s Disease (AD) | Alzheimer&Amp;Amp;#39;s Disease | Mild Alzheimer&Amp;Amp;#39;s Disease | Moderate Alzheimer&Amp;Amp;#39;s Disease | Alzheimer&Amp;#39;s DementiaUnited States
-
AphiosNot yet recruitingDementia | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3
-
Heinrich-Heine University, DuesseldorfNot yet recruitingEarly Onset Alzheimer Disease | Alzheimer Disease (AD)Germany
-
University Hospital, GrenobleRecruiting
-
Fujian Medical University Union HospitalRecruitingAlzheimer s DiseaseChina
-
AkesoNot yet recruitingAlzheimer' s DiseaseChina
-
Johns Hopkins UniversityNational Institutes of Health (NIH)Not yet recruiting
Clinical Trials on Safety in Dementia
-
Ann & Robert H Lurie Children's Hospital of ChicagoRobert Wood Johnson Foundation; Kohl's Cares for Kids Safety NetworkCompleted
-
Massachusetts General HospitalNot yet recruitingCognitive Impairment | Dementia | Alzheimer Disease | Dementia With Behavioral DisturbanceUnited States
-
Radboud University Medical CenterAlzheimer's Association; VCVGZ Fund;; Dutch Occupational Therapy AssociationUnknownCommunity Occupational Therapy | Dementia Patients | Primary Caregivers of Dementia PatientsNetherlands
-
Johns Hopkins UniversityAmerican SIDS InstituteActive, not recruiting
-
Indiana UniversityNational Institute on Aging (NIA); Regenstrief Institute, Inc.Completed
-
University of North Carolina, Chapel HillNational Institute of Nursing Research (NINR)Completed
-
Sunnybrook Health Sciences CentreCanadian Institutes of Health Research (CIHR)Completed
-
Queen's UniversityCompleted
-
Fujian Medical UniversityNot yet recruitingDementia | Primary Health Care Providers
-
Michael E. DeBakey VA Medical CenterSouth Central VA Mental Illness Research, Education & Clinical CenterUnknown